Inventor · disambiguated record
Joseph Pike Mitchener, Jr.
Also filed as: MITCHENER JOSEPH PIKE · MITCHENER JOSEPH PIKE JR · MITCHENER JR JOSEPH PIKE
12 granted patents·7 pending applications·106 citations·filing 2006–2024
92Inventor score
Files withOYSTER POINT PHARMA INC6BRISTOL DAVID WILLIAM4AKIREDDY SRINIVASA RAO2TARGACEPT INC2BHATTI BALWINDER SINGH1
Top patents by PatentIndex Score
19 records- 0198US11542253B2Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidineOYSTER POINT PHARMA INC·Filed 2021·Granted Jan 3, 2023·6 cites·10 claims
- 0297US10919879B2Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidineOYSTER POINT PHARMA INC·Filed 2019·Granted Feb 16, 2021·7 cites·9 claims
- 0396US10421745B2Salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidineOYSTER POINT PHARMA INC·Filed 2018·Granted Sep 24, 2019·10 cites·14 claims
- 0496US9145396B2Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidineTARGACEPT INC·Filed 2013·Granted Sep 29, 2015·16 cites·3 claims
- 0595US9981949B2Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidineOYSTER POINT PHARMA INC·Filed 2016·Granted May 29, 2018·8 cites·14 claims
- 0693US8859622B1Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistanceBRISTOL DAVID WILLIAM·Filed 2008·Granted Oct 14, 2014·18 cites·8 claims
- 0791US2024246936A1Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidineOYSTER POINT PHARMA INC·Filed 2024·Application pending·0 cites
- 0889US7718649B1Physical states of a pharmaceutical drug substancePISGAH LABS INC·Filed 2006·Granted May 18, 2010·13 cites·79 claims
- 0988US8604191B2Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3YLVINYL)pyrimidineAKIREDDY SRINIVASA RAO·Filed 2009·Granted Dec 10, 2013·12 cites·7 claims
- 1088US8153821B2CompoundsAKIREDDY SRINIVASA RAO·Filed 2009·Granted Apr 10, 2012·9 cites·5 claims
- 1184US8039461B1Physical states of a pharmaceutical drug substancePISGAH LAB INC·Filed 2007·Granted Oct 18, 2011·3 cites·39 claims
- 1283US8575151B1Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistanceBRISTOL DAVID WILLIAM·Filed 2008·Granted Nov 5, 2013·2 cites·24 claims
- 1383US2023295126A1Synthesis and novel salt forms of (r)-5-((e)-2-pyrrolidin-3-ylvinyl)pyrimidineOYSTER POINT PHARMA INC·Filed 2022·Application pending·0 cites
- 1481US8334322B1Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistanceBRISTOL DAVID WILLIAM·Filed 2011·Granted Dec 18, 2012·2 cites·209 claims
- 1567US2008293695A1Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistanceBRISTOL DAVID WILLIAM·Filed 2007·Application pending·0 cites
- 1665US2016046609A1Synthesis and novel salt forms of (r)-5-((e)-2-pyrrolidin-3ylvinyl)pyrimidineTARGACEPT INC·Filed 2015·Application pending·0 cites
- 1763US2025313540A1Process for the preparation of [1,4,5]-oxadiazepine derivativesSYNGENTA CROP PROTECTION AG·Filed 2023·Application pending·0 cites
- 1854US2014107163A1Synthesis and novel salt forms of (r)-3-((e)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridineTARGECEPT INC·Filed 2013·Application pending·0 cites
- 1933US2012053168A1Fused benzoazepines as neuronal nicotinic acetylcholine receptor ligandsBHATTI BALWINDER SINGH·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →